Skip to main content

Table 2 Antibiotic susceptibility testing of Isolated strains

From: A retrospective cross-sectional survey on nosocomial bacterial infections and their antimicrobial susceptibility patterns in hospitalized patients in northwest of Iran

(n%) Antibiotic susceptibility patterns
Bacterial isolates    SXT GM AN NA CRO CP FM CN E
G +  S. aureus S 3 (13.0%) 10 (43.5%) 16 (69.6%) ND ND 10 (43.5%) ND 2 (8.7%) 0 (0%)
  I 1 (4.3%) 9 (39.1%) 3 (13.0%) ND ND 3 (13.0%) ND 6 (26.1%) 1 (4.3%)
  R 19 (82.6%) 4 (17.4%) 4 (17.4%) ND ND 10 (43.5%) ND 15 (65.2%) 22 (95.7%)
  S. saprophyticus S 3 (30.0%) 3 (30.0%) 9 (90.0%) ND ND 4 (40.0%) ND 8 (80.0%) 2 (20.0%)
  I 1 (10.0%) 4 (40.0%) 0 (0%) ND ND 3 (30.0%) ND 1 (10.0%) 1 (10.0%)
  R 6 (60.0%) 3 (30.0%) 1 (10.0%) ND ND 3 (30.0%) ND 1 (10.0%) 7 (70.0%)
  S. epidermidis S 1 (12.5%) 5 (62.5%) 3 (37.5%) ND ND 3 (37.5%) ND 3 (37.5%) 0 (0%)
  I 0 (0%) 1 (12.5%) 0 (0%) ND ND 0 (0%) ND 2 (25.0%) 0 (0%)
  R 7 (87.5%) 2 (25.0%) 5 (62.5%) ND ND 5 (62.5%) ND 3 (37.5%) 8 (100.0%)
  E. faecalis S 0 (0%) 1 (25.0%) 2 (50.0%) ND ND 0 (0%) ND 0 (0%) 0 (0%)
  I 0 (0%) 0 (0%) 0 (0%) ND ND 0 (0%) ND 1 (25.0%) 0 (0%)
  R 4 (100%) 3 (75.0%) 2 (50.0%) ND ND 4 (100.0%) ND 3 (75.0)% 4 (100.0%)
  E. faecalis S 0 (0%) 2 (66.7%) 2 (66.7%) ND ND 2 (66.7%) ND 2 (66.7%) 1 (33.3%)
  I 0 (0%) 1 (33.3%) 0 (0%) ND ND 1 (33.3%) ND 0 (0%) 0 (0%)
   R 3 (100.0%) 0 (0%) 1 (33.3%) ND ND 0 (0%) ND 1 (33.3%) 2 (66.7%)
G- E. coli S 122 (33.9%) 101 (28.1%) ND 88 (24.4%) 189 (52.5%) 224 (62.2%) 198 (55.0%) ND ND
   I 10 (2.8%) 195 (54.2%) ND 45 (12.5%) 17 (4.7%) 16 (4.4%) 123 (34.2%) ND ND
   R 228 (63.3%) 64 (17.8%) ND 227 (63.1%) 154 (42.8%) 120 (33.3%) 39 (10.8%) ND ND
  Citribacter spp S 7 (28.0%) 11 (44.0%) ND 0 (0%) 11 (44.0%) 16 (64.0%) 10 (40.0%) ND ND
   I 2 (8.0%) 10 (40.0%) ND 2 (8.0%) 2 (8.0%) 2 (8.0%) 12 (48.0%) ND ND
   R 16 (64.0%) 4 (16.0%) ND 23 (92.0%) 12 (48.0%) 7 (28.0%) 3 (12.0%) ND ND
  Klebsiella spp S 12 (27.3%) 10 (22.7%) ND 6 (13.6%) 15 (34.1%) 27 (61.4%) 15 (34.1%) ND ND
   I 4 (9.1%) 22 (50.0%) ND 6 (13.6%) 1 (2.3%) 1 (2.3%) 6 (13.6%) ND ND
   R 28 (63.6%) 12 (27.3%) ND 32 (72.7%) 28 (63.6%) 16 (36.4%) 23 (52.3%) ND ND
  Enterobacter spp S 5 (31.2%) 5 (31.2%) ND 1 (6.2%) 3 (18.8%) 9 (56.2%) 8 (50.0%) ND ND
   I 2 (12.5%) 3 (18.8%) ND 2 (12.5%) 2 (12.5%) 0 (0%) 4 (25.0%) ND ND
   R 9 (56.2%) 8 (50.0%) ND 13 (81.2%) 11 (68.8%) 7 (43.8%) 4 (25.0%) ND ND
  Serratia S 1 (100.0%) 0 (0%) ND 0 (0%) 1 (100.0%) 1 (100.0%) 0 (0%) ND ND
   I 0 (0%) 1 (100%) ND 0 (0%) 0 (0%) 0 (0%) 1 (100.0%) ND ND
   R 0 (0%) 0 (0%) ND 1 (100.0%) 0 (0%) 0 (0)% 0 (0%) ND ND
  Proteus spp S 1 (50.0%) 1 (50.0%) ND 0 (0%) 2 (100.0%) 2 (100.0%) 0 (0%) ND ND
   I 0 (0%) 1 (50.0%) ND 1 (50%) 0 (0%) 0 (0%) 0 (0%) ND ND
   R 1 (50.0%) 0 (0%) ND 1 (50%) 0 (0%) 0 (0%) 2 (100.0%) ND ND
  P. aeruginosa S 0 (0%) 2 (22.2%) ND 0 (0%) 2 (22.2%) 4 (44.4%) 0 (0%) ND ND
   I 0 (0%) 3 (33.3%) ND 0 (0%) 2 (22.2%) 1 (11.1%) 0 (0%) ND ND
   R 9 (100%) 4 (44.4%) ND 9 (100.0%) 5 (55.6%) 4 (44.4%) 9 (100.0%) ND ND
  Acinetobacter S 0 (0%) 0 (0%) ND 0 (0%) 0 (0%) 2 (66.7%) 1 (33.3%) ND ND
   I 0 (0%) 2 (66.7%) ND 0 (0%) 0 (0%) 2 (66.7%) 0 (0%) ND ND
   R 3 (100%) 1 (33.3%) ND 3 (100.0%) 3 (100.0%) 1 (33.1%) 2 (66.7%) ND ND
  Shigella sonnei S 0 (0%) 1 (100.0%) ND 0 (0%) 1 (100.0%) 0 (0%) 0 (0%) ND ND
   I 0 (0%) 0 (0%) ND 0 (0%) 0 (0%) 0 (0%) 1 (100.0%) ND ND
   R 1 (100.0%) 0 (0%) ND 1 (100.0%) 0 (0%) 1 (100.0%) 0 (0%) ND ND
  1. G+ Gram positive bacteria, G− gram negative bacteria, S sensitive, I intermediate, R resistant, ND not determined, SXT cotrimoxazole, GM gentamycin, AN amikacin, NA nalidixic acid, CRO ceftriaxone, FM nitrofurantoin, CN cephalexin, E erythromycin